Program Focus
The overall aim is to understand how to manage the
safety life-cycle of the Company products whether in
clinical development or post-marketing.
Additionally, day 2 of the course looks at the safety of
Medical Devices through the introduction of the new EU
Legislation which came into force in May 2021 & 2022.
Specific objectives are:
- To provide a clear approach to signal detection.
- Identify how to translate signals into practical safety
information to explain how products can still be used
effectively.
- To provide an overview of the digitalisation
opportunities in the pharmaceutical industry that will
contribute to earlier and better signalling.
- Changes imposed by the new EU Medical Device
Legislation
- The impact of those changes in terms of enhanced
safety monitoring
- The implication of Brexit on Device Vigilance